Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says

NDTV Profit 2022-02-26

Views 4

Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Laurus Labs' Q2 Report Card & H2 Guidance: Talking Point
play
30:49

Laurus Labs' Q2 Report Card & H2 Guidance: Talking Point
Q2 Review: Laurus Labs Founder & CEO On Earnings & Growth Targets
play
21:37

Q2 Review: Laurus Labs Founder & CEO On Earnings & Growth Targets
Laurus Labs In Focus | Ask Profit | NDTV Profit
play
00:00

Laurus Labs In Focus | Ask Profit | NDTV Profit
Q1 Review | Laurus Labs' Founder Shares Earnings Insights
play
23:30

Q1 Review | Laurus Labs' Founder Shares Earnings Insights
Q3 Review| Laurus Labs Growth Strategies For Coming Quarters
play
23:30

Q3 Review| Laurus Labs Growth Strategies For Coming Quarters
Q2 Review: Laurus Labs' Profit Nosedives 84% In Second Quarter
play
27:08

Q2 Review: Laurus Labs' Profit Nosedives 84% In Second Quarter
Laurus Labs Forays Into Biotech Segment Via Acquisition
play
12:41

Laurus Labs Forays Into Biotech Segment Via Acquisition
Talking Point With Laurus Labs' Satyanarayana Chava
play
35:10

Talking Point With Laurus Labs' Satyanarayana Chava
Laurus Labs In Focus | Profit Insight | NDTV Profit
play
00:00

Laurus Labs In Focus | Profit Insight | NDTV Profit
Stocks In Focus: ITI, Laurus Labs, L&T, JSW Steel & More | BQ Prime
play
12:40

Stocks In Focus: ITI, Laurus Labs, L&T, JSW Steel & More | BQ Prime
Q4 Review: Laurus Labs' Plans To Accelerate Growth In FY23
play
26:05

Q4 Review: Laurus Labs' Plans To Accelerate Growth In FY23
Laurus Labs Management On Q1 Report Card & More
play
20:29

Laurus Labs Management On Q1 Report Card & More